Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 741

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 741
---
 an exception to any of, such BC Party’s representations and warranties contained in this Agreement or any other Transaction Document. “

#### Required Holders
” means each of Nomis Bay and Ligand (collectively, the “

#### Lead Buyers
”) for so long as either Lead Buyer continues to hold any Securities, and thereafter, holders of a majority of the aggregate stated value of the Securities then held by all remaining Investors (except, that Section 4(o) shall only be permitted to be amended, modified or waived with the consent of the Lead Buyers).

<div align='center'>B-33</div>

TABLE OF CONTENTS

(f) Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party does not receive an automatically generated message from the recipient’s email server that such e-mail could not be delivered to such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:

| If to the Company:                                                                   |     |                                    |     |                              |
|                                                                                      |     | Channel Therapeutics Corporation   |     |                              |
|                                                                                      |     | 4400 Route 9 South, Suite 1000     |     |                              |
|                                                                                      |     | Freehold, NJ 07728                 |     |                              |
|                                                                                      |     | Telephone:                         |     |                              |
|                                                                                      |     | Attention:                         |     | Chief Executive Officer      |
|                                                                                      |     | E-Mail:                            |     |                              |
| With a copy (for informational purposes only) to:                                    |     |                                    |     |                              |
|                                                                                      |     | 1251 Avenue of the Americas        |     |                              |
|                                                                                      |     | New York, NY 10020                 |     |                              |
|                                                                                      |     | Telephone:                         |     |                              |
|                                                                                      |     | Attention:                         |     | David Danovitch, Esq.        |
|                                                                                      |     |